Breakthrough as scientists use AI to predict how breast cancer could progress

Researchers at the University of Southampton developed CenSegNet, an AI platform that analyzes centrosome abnormalities in breast cancer tumors. It identifies distinct centrosome defects linked to tumor aggressiveness and patient survival, enabling better progression forecasts and personalized treatments.